The pharmaceutical industry plays a critical role in improving global health, but it also generates significant amounts of wastewater during its manufacturing processes. To address the environmental impact, pharmaceutical companies are increasingly adopting sustainable practices like Zero Liquid Discharge (ZLD). In this blog, we will explore the concept of ZLD and discuss different techniques and benefits of implementing it in pharmaceutical industries.
Understanding Zero Liquid Discharge
Zero Liquid Discharge is an innovative water management approach that aims to eliminate the discharge of wastewater from industrial processes. Instead of releasing effluent into water bodies, ZLD systems treat and recover water, enabling its reuse or conversion into valuable resources like clean water, salts, and solids. For pharmaceutical industries, ZLD offers an effective solution to minimize their water footprint and protect the environment.
Get in Touch with us for Zero Liquid Discharge
Pharmaceutical plants are significant contributors to effluent generation due to their complex manufacturing processes and the nature of the substances they handle. These plants produce effluents through various stages, including raw material preparation, synthesis, purification, and formulation. These processes involve the use of solvents, chemicals, and water, leading to the generation of effluents containing pharmaceutical residues, organic compounds, heavy metals, and other pollutants. Effluent generation is further compounded by the need for strict quality control, frequent equipment cleaning, and waste disposal. To mitigate environmental impact, pharmaceutical plants employ wastewater treatment systems and adopt best practices for waste management, but effluent generation remains a challenge in the industry.
Zero Liquid Discharge Techniques in Pharmaceutical Industries
A. Advanced Water Treatment: Pharmaceutical wastewater contains complex and potentially harmful compounds. Advanced treatment technologies like membrane filtration, reverse osmosis, Demineralisation plants, Electro demineralization Units, and activated carbon adsorption effectively remove impurities, contaminants, and even trace amounts of pharmaceutical compounds.
B. Membrane Technologies: Membrane processes such as reverse osmosis,, Ultrafiltration, and nanofiltration play a crucial role in purifying wastewater, separating dissolved solids, and producing reusable water.
C. Evaporation and Crystallization: Evaporation techniques concentrate the wastewater which contains high BOD, COD, and volatile wastewater into water vapours and later into condensate water leaving behind solid salts that can be further processed into valuable byproducts. Crystallization helps in the recovery of high-purity salts, reducing the need for fresh raw materials.
About Scaleban
Scaleban offers a holistic solution tailored to address the specific challenges encountered by pharmaceutical industries when utilizing wastewater in their cooling tower systems. Its comprehensive approach effectively tackles hard water scaling, corrosion, bio-fouling, and Total Suspended Solids (TSS) removal, ensuring the efficient and sustainable operation of cooling towers in this context.
Get in Touch with us for Zero Liquid Discharge
In pharmaceutical manufacturing facilities, the presence of high hardness levels in wastewater can lead to the formation of scale when used in cooling tower, impacting heat transfer efficiency and requiring frequent maintenance and cleaning. To combat this, Scaleban equipment is strategically installed at the heat exchanger inlets within the cooling tower circuit. This installation prevents scale formation, thereby optimizing heat transfer efficiency and reducing the need for maintenance interventions.
Furthermore, pharmaceutical cooling towers often operate in high Total Dissolved Solids (TDS) environments, increasing the risk of corrosion in system components. Scaleban incorporates specialized corrosion inhibitors that effectively protect the cooling tower infrastructure. By mitigating the risks associated with corrosion, these inhibitors extend the lifespan of the equipment and ensure reliable performance.
Bio-fouling, which includes the growth of bacteria and algae, is another challenge in pharmaceutical cooling towers. Scaleban employs specially formulated biocides that are precisely dosed into the cooling tower sump. This approach effectively inhibits the growth of microorganisms, ensuring optimal heat transfer efficiency and maintaining a hygienic cooling tower environment.
Additionally, Scaleban integrates a Glass Media-based Pre-Filtration system to remove insoluble particles, such as Total Suspended Solids (TSS), from the wastewater. By reducing the particulate matter, this pre-filtration step protects downstream equipment and improves overall water quality.
By combining these approaches, Scaleban offers a comprehensive solution specifically designed for pharmaceutical industries utilizing wastewater in their cooling tower systems. It effectively addresses the challenges of hard water scaling, corrosion, bio-fouling, and TSS removal. This integrated system enables pharmaceutical manufacturers to manage the complexities associated with wastewater usage in cooling towers, promoting sustainable water management practices while ensuring optimal system performance and longevity.
UN SDG 6: Clean Water and Sanitation
Zero liquid discharge systems in industries play a crucial role in mitigating water pollution caused by industrial effluents. These systems remove pollutants, contaminants, and harmful substances from wastewater, making it suitable for discharge or reuse. Through the adoption, industries play a vital role in safeguarding water resources, preventing the pollution of freshwater bodies, and conserving aquatic ecosystems. This concerted effort contributes to the availability of clean water, upholding the fundamental human right to access clean water and sanitation.
Moreover, the implementation of Zero Liquid discharge systems in industries supports the sustainable management of water resources. These systems efficiently treat wastewater and reduce water discharge, thereby fostering water conservation and optimizing water utilization. This alignment with the objectives of SDG 6 underscores the significance of adopting sustainable water management practices to guarantee the provision of clean water for communities, industries, and ecosystems.
UN SDG 7: Affordable and Clean Energy
ZLD systems also contribute to SDG 7 by incorporating energy-efficient technologies and practices. These systems employ energy-intensive processes, such as filtration and disinfection, but by adopting energy-efficient technologies, they help reduce energy consumption and greenhouse gas emissions. This aligns with the objective of achieving affordable and clean energy. Furthermore, ZLD systems support the concept of “Energy Recovery from Waste” (ERW) by utilizing anaerobic digestion to generate biogas from organic waste present in wastewater. This renewable energy source can replace traditional fossil fuels and contribute to cleaner and more sustainable energy production.
By implementing Zero liquid discharge systems in industries, India can make significant strides toward achieving SDG 6 and SDG 7. These systems promote the availability of clean water, sustainable water management practices, energy efficiency, and the utilization of renewable energy sources.
Conclusion
Zero Liquid Discharge is a must as a sustainable solution for the pharmaceutical industry, addressing the environmental impact of wastewater generation. By implementing techniques, pharmaceutical companies can minimize their water footprint, protect water resources, and contribute to a greener future. The benefits of ZLD extend beyond environmental preservation, encompassing regulatory compliance, resource recovery, and enhanced sustainability. As more pharmaceutical companies recognize the importance of responsible water management, the adoption of ZLD will continue to grow, fostering a more sustainable and socially responsible industry.